Quality Assurance (QA) – Page 3

Deviation closed without effectiveness check during QA review – GDP documentation do’s and don’ts

Identifying symptoms associated with deviations closed without an effectiveness check is critical for timely resolution. Symptoms may manifest as increased batch rejections, an uptick in customer complaints, or higher levels…

Batch disposition delayed during regulatory inspection readiness – GDP documentation do’s and don’ts

Symptoms signaling potential delays in batch disposition can originate from various processes within the pharmaceutical manufacturing lifecycle. Below are common signals that should heighten awareness:Click to read the full article.

Deviation closed without effectiveness check during complaint triage – CAPA effectiveness verification framework

Recognizing symptoms or signals promptly is the first step in managing a deviation effectively. These signals can emerge through various channels such as internal quality checks, routine audits, or complaints…

Inconsistent SOP interpretation during QA review – risk-based justification template for decisions

Recognizing symptoms of inconsistent SOP interpretation is crucial for initiating a timely investigation. Typical signals include:Click to read the full article.

Supplier deviation not assessed during management review – GDP documentation do’s and don’ts

Identifying the signals that indicate a supplier deviation may have gone unassessed is crucial for early intervention. Common symptoms include:Click to read the full article.

CAPA overdue beyond target date during complaint triage – risk-based justification template for decisions

Addressing CAPA Delays Beyond Target Dates During Complaint Triage In the highly regulated pharmaceutical industry, timely corrective and preventive actions (CAPA) are crucial to maintaining compliance and ensuring product quality.…

Batch disposition delayed during change control governance – GDP documentation do’s and don’ts

When batch disposition delays occur, certain symptoms or signals may become apparent on the production floor or within the laboratory environment. Recognizing these indicators early can help teams respond appropriately…

Audit finding not escalated during internal audit follow-up – risk-based justification template for decisions

When an audit finding is not escalated, several symptoms may manifest on the shop floor or within laboratory operations. Some indications that a significant issue has not been adequately addressed…

Supplier deviation not assessed during management review – CAPA effectiveness verification framework

Identifying the initial symptoms or signals indicative of supplier deviations is crucial to initiating timely investigations. Common signals that could suggest a supplier deviation not adequately assessed might include:Click to…

Training evidence weak during management review – CAPA effectiveness verification framework

Identifying the symptoms related to weak training evidence is crucial to addressing compliance gaps. Common signals or symptoms that may arise during management reviews include:Click to read the full article.

Training evidence weak during management review – risk-based justification template for decisions

Weak training evidence often manifests through various signals that can be early indicators of broader compliance issues. Common signs to monitor include:Click to read the full article.

Inconsistent SOP interpretation during internal audit follow-up – how to prevent repeat observations

The first step in addressing inconsistent SOP interpretations is identifying the symptoms or signals associated with this issue. Symptoms may manifest as:Click to read the full article.